Search

Author/Creator Cohen, AD

1. B07: SAFETY AND EFFICACY OF CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY DIRECTED AGAINST B-CELL MATURATION ANTIGEN IN PATIENTS WITH MULTIPLE MYELOMA AND EARLY RELAPSE AFTER INITIAL THERAPY: CARTITUDE-2 RESULTS. (5th April 2022)

Authors:
van de Donk, NWCJ; Delforge, M; Agha, M; Cohen, AD; Cohen, YC; Hillengass, J; Anguille, S; Kerre, T; Roeloffzen, W; Schecter, JM; De Braganca, KC; Varsos, H; Wang, L; Vogel, M; Zudaire, E; Corsale, C; Akram, M; Geng, D; Nesheiwat, T; Pacaud, L
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 2
Page Start:
9
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P08: CARTITUDE-2 UPDATE: CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY. (5th April 2022)

Authors:
Einsele, H; Cohen, AD; Delforge, M; Hillengass, J; Goldschmidt, H; Weisel, K; Raab, M-S; Scheid, C; Schecter, JM; De Braganca, KC; Varsos, H; Yeh, T-M; Wang, L; Vogel, M; Corsale, C; Akram, M; Pacaud, L; Nesheiwat, T; Agha, M; Cohen, YC
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 2
Page Start:
15
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline. Issue 1 (31st October 2020)

Authors:
Tudorascu, DL; Laymon, CM; Zammit, M; Minhas, DS; Anderson, SJ; Ellison, PA; Zaman, S; Ances, BM; Sabbagh, M; Johnson, SC; Mathis, CA; Klunk, WE; Handen, BL; Christian, BT; Cohen, AD
Journal:
Alzheimer's & dementia
Issue:
Volume 6:Issue 1(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗